PMA supplement
P900030 S001: CONTIGEN (TM) BARD (R) COLLAGEN IMPLANT
FDA PMA supplement · Normal 180 Day Track · Allergan, Inc.
Key facts
| Original PMA | P900030 |
|---|---|
| Supplement number | S001 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | CONTIGEN (TM) BARD (R) COLLAGEN IMPLANT |
| Generic name | AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE |
| Applicant | Allergan, Inc. |
| Product code | LNM |
| Received date | Nov 15, 1993 |
| Decision date | Mar 28, 1994 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: